UniProt ID | VRK3_HUMAN | |
---|---|---|
UniProt AC | Q8IV63 | |
Protein Name | Inactive serine/threonine-protein kinase VRK3 | |
Gene Name | VRK3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 474 | |
Subcellular Localization | Nucleus . | |
Protein Description | Inactive kinase that suppresses ERK activity by promoting phosphatase activity of DUSP3 which specifically dephosphorylates and inactivates ERK in the nucleus.. | |
Protein Sequence | MISFCPDCGKSIQAAFKFCPYCGNSLPVEEHVGSQTFVNPHVSSFQGSKRGLNSSFETSPKKVKWSSTVTSPRLSLFSDGDSSESEDTLSSSERSKGSGSRPPTPKSSPQKTRKSPQVTRGSPQKTSCSPQKTRQSPQTLKRSRVTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMVP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MISFCPDCGK -----CCEECCCCCH | 21.35 | 25002506 | |
11 | Phosphorylation | FCPDCGKSIQAAFKF ECCCCCHHHHHHHHH | 12.76 | 25002506 | |
50 | Methylation | SSFQGSKRGLNSSFE HHCCCCCCCCCCCCC | 57.43 | 115919865 | |
54 | Phosphorylation | GSKRGLNSSFETSPK CCCCCCCCCCCCCCC | 41.25 | 22167270 | |
55 | Phosphorylation | SKRGLNSSFETSPKK CCCCCCCCCCCCCCC | 26.48 | 23401153 | |
58 | Phosphorylation | GLNSSFETSPKKVKW CCCCCCCCCCCCCCC | 48.60 | 30266825 | |
59 | Phosphorylation | LNSSFETSPKKVKWS CCCCCCCCCCCCCCC | 27.76 | 19664994 | |
66 | Phosphorylation | SPKKVKWSSTVTSPR CCCCCCCCCCCCCCC | 15.48 | 26853621 | |
67 | Phosphorylation | PKKVKWSSTVTSPRL CCCCCCCCCCCCCCE | 26.28 | 30576142 | |
68 | Phosphorylation | KKVKWSSTVTSPRLS CCCCCCCCCCCCCEE | 23.45 | 26853621 | |
70 | Phosphorylation | VKWSSTVTSPRLSLF CCCCCCCCCCCEEEC | 32.85 | 25159151 | |
71 | Phosphorylation | KWSSTVTSPRLSLFS CCCCCCCCCCEEECC | 12.04 | 25159151 | |
71 | O-linked_Glycosylation | KWSSTVTSPRLSLFS CCCCCCCCCCEEECC | 12.04 | 30379171 | |
75 | Phosphorylation | TVTSPRLSLFSDGDS CCCCCCEEECCCCCC | 28.75 | 22115753 | |
78 | Phosphorylation | SPRLSLFSDGDSSES CCCEEECCCCCCCCC | 46.08 | 25159151 | |
82 | Phosphorylation | SLFSDGDSSESEDTL EECCCCCCCCCCCCC | 41.35 | 25159151 | |
83 | Phosphorylation | LFSDGDSSESEDTLS ECCCCCCCCCCCCCC | 50.29 | 25159151 | |
85 | Phosphorylation | SDGDSSESEDTLSSS CCCCCCCCCCCCCHH | 42.60 | 30278072 | |
88 | Phosphorylation | DSSESEDTLSSSERS CCCCCCCCCCHHHHC | 25.20 | 22115753 | |
90 | Phosphorylation | SESEDTLSSSERSKG CCCCCCCCHHHHCCC | 33.63 | 19690332 | |
91 | Phosphorylation | ESEDTLSSSERSKGS CCCCCCCHHHHCCCC | 39.05 | 23403867 | |
92 | Phosphorylation | SEDTLSSSERSKGSG CCCCCCHHHHCCCCC | 33.38 | 23403867 | |
95 | Phosphorylation | TLSSSERSKGSGSRP CCCHHHHCCCCCCCC | 37.00 | 24719451 | |
98 | Phosphorylation | SSERSKGSGSRPPTP HHHHCCCCCCCCCCC | 37.01 | 23403867 | |
100 | Phosphorylation | ERSKGSGSRPPTPKS HHCCCCCCCCCCCCC | 43.22 | 23403867 | |
104 | Phosphorylation | GSGSRPPTPKSSPQK CCCCCCCCCCCCCCC | 46.13 | 22617229 | |
107 | Phosphorylation | SRPPTPKSSPQKTRK CCCCCCCCCCCCCCC | 48.75 | 23403867 | |
107 | O-linked_Glycosylation | SRPPTPKSSPQKTRK CCCCCCCCCCCCCCC | 48.75 | 30379171 | |
108 | Phosphorylation | RPPTPKSSPQKTRKS CCCCCCCCCCCCCCC | 37.16 | 23403867 | |
112 | Phosphorylation | PKSSPQKTRKSPQVT CCCCCCCCCCCCCCC | 37.77 | 28111955 | |
115 | Phosphorylation | SPQKTRKSPQVTRGS CCCCCCCCCCCCCCC | 19.78 | 22617229 | |
119 | Phosphorylation | TRKSPQVTRGSPQKT CCCCCCCCCCCCCCC | 24.86 | 25159151 | |
122 | Phosphorylation | SPQVTRGSPQKTSCS CCCCCCCCCCCCCCC | 22.37 | 28355574 | |
126 | Phosphorylation | TRGSPQKTSCSPQKT CCCCCCCCCCCCCCC | 29.71 | 28450419 | |
127 | Phosphorylation | RGSPQKTSCSPQKTR CCCCCCCCCCCCCCC | 21.45 | 28450419 | |
129 | Phosphorylation | SPQKTSCSPQKTRQS CCCCCCCCCCCCCCC | 30.08 | 28450419 | |
133 | Phosphorylation | TSCSPQKTRQSPQTL CCCCCCCCCCCCCHH | 28.79 | 23403867 | |
136 | Phosphorylation | SPQKTRQSPQTLKRS CCCCCCCCCCHHHHH | 18.71 | 30266825 | |
139 | Phosphorylation | KTRQSPQTLKRSRVT CCCCCCCHHHHHHCC | 37.32 | 30266825 | |
143 | Phosphorylation | SPQTLKRSRVTTSLE CCCHHHHHHCCCCEE | 29.52 | 26270265 | |
146 | Phosphorylation | TLKRSRVTTSLEALP HHHHHHCCCCEECCC | 15.01 | 26270265 | |
147 | Phosphorylation | LKRSRVTTSLEALPT HHHHHCCCCEECCCC | 28.58 | 26270265 | |
148 | Phosphorylation | KRSRVTTSLEALPTG HHHHCCCCEECCCCC | 18.17 | 26270265 | |
154 | Phosphorylation | TSLEALPTGTVLTDK CCEECCCCCCEEECC | 46.46 | 26270265 | |
156 | Phosphorylation | LEALPTGTVLTDKSG EECCCCCCEEECCCC | 18.15 | 26270265 | |
159 | Phosphorylation | LPTGTVLTDKSGRQW CCCCCEEECCCCCEE | 36.72 | 26270265 | |
161 | Ubiquitination | TGTVLTDKSGRQWKL CCCEEECCCCCEEEE | 49.96 | - | |
161 | Acetylation | TGTVLTDKSGRQWKL CCCEEECCCCCEEEE | 49.96 | 25953088 | |
169 | Ubiquitination | SGRQWKLKSFQTRDN CCCEEEEEEEECCCC | 45.56 | - | |
179 | Ubiquitination | QTRDNQGILYEAAPT ECCCCCCEEEEECCC | 2.39 | 21890473 | |
197 | Ubiquitination | TCDSGPQKQKFSLKL ECCCCCCCCCEEEEE | 59.60 | - | |
199 | Ubiquitination | DSGPQKQKFSLKLDA CCCCCCCCEEEEEEC | 43.91 | - | |
223 | Ubiquitination | NFFQRAAKPLQVNKW CHHHHHCCCCCCCHH | 45.32 | - | |
225 | Ubiquitination | FQRAAKPLQVNKWKK HHHHCCCCCCCHHHH | 9.77 | 21890473 | |
229 (in isoform 2) | Ubiquitination | - | 62.63 | 21890473 | |
229 (in isoform 1) | Ubiquitination | - | 62.63 | 21890473 | |
229 | Ubiquitination | AKPLQVNKWKKLYST CCCCCCCHHHHHHCC | 62.63 | 21890473 | |
232 | Ubiquitination | LQVNKWKKLYSTPLL CCCCHHHHHHCCCEE | 52.09 | - | |
268 | Phosphorylation | SLGRSLQSALDVSPK HHCHHHHHHHCCCHH | 35.77 | 30622161 | |
273 | Phosphorylation | LQSALDVSPKHVLSE HHHHHCCCHHHHCCH | 28.09 | 30622161 | |
275 (in isoform 1) | Ubiquitination | - | 38.55 | 21890473 | |
275 | Acetylation | SALDVSPKHVLSERS HHHCCCHHHHCCHHH | 38.55 | 23749302 | |
275 (in isoform 2) | Ubiquitination | - | 38.55 | 21890473 | |
275 | Ubiquitination | SALDVSPKHVLSERS HHHCCCHHHHCCHHH | 38.55 | 21890473 | |
338 | Ubiquitination | FRYCPSGKHVAYVEG EEECCCCCEEEEEEC | 38.96 | - | |
348 | Phosphorylation | AYVEGSRSPHEGDLE EEEECCCCCCCCCCE | 32.10 | 20873877 | |
410 | Ubiquitination | QKQKFVDKPGPFVGP HHHHHCCCCCCCCCC | 46.72 | - | |
411 (in isoform 2) | Phosphorylation | - | 51.75 | 21406692 | |
439 | Phosphorylation | LKVVMALTYEEKPPY HHHHHHHHCCCCCCH | 21.24 | 29449344 | |
440 | Phosphorylation | KVVMALTYEEKPPYA HHHHHHHCCCCCCHH | 23.96 | 29449344 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
108 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VRK3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VRK3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TWF2_HUMAN | TWF2 | physical | 17353931 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59; SER-82; SER-83 ANDSER-90, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55 AND SER-59, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY. |